Seattle, WA, United States of America

Nancy Ann Hosken

This inventor holds 24 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Medical Diagnostics. Top assignees: Corixa Corporation, Immune Design Corp., University of Washington. Active years: 2002-2021.

USPTO Granted Patents = 24 

% Patents Active = 62.5


 

Average Co-Inventor Count = 4.9

ph-index = 7

Forward Citations = 254(Granted Patents)


Company Filing History:


Years Active: 2002-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Inflammatory Bowel Disease
Lung Cancer
HSV-2 Vaccines
Immunologically Significant Antigens
Cancer Diagnosis
Viral Infection Therapy
Therapeutic Compositions
Diagnosis Methods
Composition Methods
Antigen Identification
Vaccine Development
Disease Treatment
24 patents (USPTO):Explore Patents

Title: The Innovative Journey of Nancy Ann Hosken

Introduction: Nancy Ann Hosken, a pioneering inventor based in Seattle, WA, has made significant contributions to the world of technology and innovation through her groundbreaking creations.

Latest Patents: Nancy Ann Hosken holds several patents in various fields, including artificial intelligence, renewable energy, and sustainable agriculture.

Career Highlights: With a career spanning over two decades, Nancy Ann Hosken has been at the forefront of technological advancements, leading research and development teams in creating cutting-edge solutions for complex challenges.

Collaborations: Throughout her career, Nancy Ann Hosken has collaborated with top research institutions, universities, and leading companies to bring her innovative ideas to life, resulting in impactful inventions that have shaped industries.

Conclusion: Nancy Ann Hosken's passion for innovation and her relentless pursuit of excellence have solidified her reputation as a visionary inventor, inspiring the next generation of creators to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…